Investor Relations
By helping our clients to consistently outperform and build a strong foundation for the future, Cowen aims to deliver long-term value for our shareholders.
FINANCIALS
Explore our SEC filings, corporate governance information and other shareholder information. Take a moment to read our latest Annual Report.
QUICK LINKS
- Annual Report
- Quarterly earnings
- Latest news
- Stock chart update
- Historical price lookup
- Stockholder services
- Analyst Coverage
- Investor Presentations
- Subsidiary Financial Statements
Stay up to date
GET IN TOUCH
Cowen Investor inquiries will be routed to Steve Lasota, CFO
Stock Quote
COWN
Exchange NASDAQ (USD)
Price $38.67
Change +0.07 / +0.18%
Volume 421,341
Data as of 10/06/2022 4:00 PM UTC.
Minimum 15 minute delay.
News
ACELYRIN, INC. Announces $300 Million Series C Financing to Accelerate Phase 3 Development of Izokibep, a Unique IL-17A Inhibitor to Treat Inflammatory Diseases
Read the article “ACELYRIN, INC. Announces $300 Million Series C Financing to Accelerate Phase 3 Development of Izokibep, a Unique IL-17A Inhibitor to Treat Inflammatory Diseases”
Aktis Oncology Raises $84 Million to Advance Novel Targeted Alpha Radiopharmaceuticals
Read the article “Aktis Oncology Raises $84 Million to Advance Novel Targeted Alpha Radiopharmaceuticals”
Cowen Digital Expands Institutional Team with Crypto-Native Hires
Read the article “Cowen Digital Expands Institutional Team with Crypto-Native Hires”
